Business
Announcement on Reply to Letter of Supervision and Inquiry of 2025 Annual Report
Announcement on Reply to Letter of Supervision and Inquiry of 2025 Annual Report
About this update from Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A
Announcement on Reply to Letter of Supervision and Inquiry of 2025 Annual Report The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment